CHEMICAL
ASSESSMENTS
Status of EPAs Efforts
to Produce
Assessments and
Implement the Toxic
Substances Control
Act
Report to the Ranking Member,
Committee on Environment and Public
Works, U.S. Senate
March 2019
GAO-19-270
United States Government Accountability Office
United States Government Accountability Office
Highlights of GAO-19-270, a report to the
Ranking Member, Committee on Environment
and Public Works, U.S. Senate
March 2019
C
HEMICAL ASSESSMENTS
Status of
EPA’s Efforts to Produce Assessments and
Implement the Toxic Substances Control Act
What GAO Found
The Environmental Protection Agency’s (EPA) Integrated Risk Information
System (IRIS) Program, which prepares human health toxicity assessments of
chemicals, has made progress addressing historical timeliness and transparency
challenges in the assessment process. Efforts to address timeliness include
employing project management principles and specialized software to better plan
assessments and utilize staff. To address the need for greater transparency in
how the program conducts assessments, IRIS officials and the IRIS Program
have implemented systematic review, which provides a structured and
transparent process for identifying relevant studies, reviewing their
methodological strengths and weaknesses, and integrating these studies as part
of a weight of evidence analysis.
Since the process improvements were implemented, the program made progress
toward producing chemical assessments through May 2018. In June 2018, the
EPA Administrator’s office told IRIS officials that they could not release any IRIS-
associated documentation without a formal request from EPA program office
leadership. In August 2018, according to IRIS officials, program office leadership
was asked to reconfirm which ongoing chemical assessments their offices
needed. In late October 2018, these offices were asked to limit their chemical
requests further, to the top three or four assessments. At the same time4
months after IRIS assessments were stopped from being released28 of
approximately 30 IRIS staff were directed to support implementation of the Toxic
Substances Control Act of 1976 (TSCA), as amended, with 25 to 50 percent of
their time, according to officials. Then on December 19, 2018, the Office of
Research and Development released its IRIS Program Outlook, which provided
an updated list of 13 assessments. Eleven of the 13 chemicals on the IRIS
Program Outlook were requested by two EPA program offices. A memorandum
issued earlier in December, gave no indication of when additional assessments
could be requested or what the IRIS Program’s workflow would be in the near
term.
EPA has demonstrated progress implementing TSCA, which was amended in
June 2016, by responding to statutory deadlines. For example, EPA finalized
rules detailing the general processes for prioritizing and evaluating chemicals,
known as the Framework Rules, but three of the four rules have been challenged
in court. Environmental organizations have argued, among other things, that
TSCA requires EPA to consider all conditions of use in prioritizing and evaluating
chemicals, rather than excluding, for example, uses that EPA believes are
"legacy uses," for which a chemical is no longer marketed. EPA argued that
TSCA grants it discretion to determine what constitutes a chemical’s conditions
of use. Amendments to TSCA in 2016 increased EPA’s responsibility for
regulating chemicals and in turn, its workload. As such, EPA is required to
prioritize and evaluate existing chemicals by various deadlines over an extended
period and to make a regulatory determination on all new chemicals. Senior
management told GAO that they were confident that ongoing hiring and
reorganization would better position the office that implements TSCA.
View GAO-19-270. For more information,
contact
J. Alfredo Gómez at (202) 512-
.
Why GAO Did This Study
EPA is responsible for reviewing
chemicals in commerce and those
entering the marketplace. Currently
there are more than 40,000 active
chemical substances in commerce,
with more submitted to EPA for review
annually. EPA’s IRIS database
contains the agency’s scientific
position on the potential human health
effects that may result from exposure
to various chemicals in the
environment. EPA’s IRIS Program,
which produces toxicity assessments,
has been criticized in the past for
timeliness and transparency issues. In
response, the IRIS Program committed
to making program improvements
starting in 2011, which the National
Academy of Sciences (NAS) recently
commended. TSCA as amended in
2016 provides EPA with additional
authority to review both existing and
new chemicals and to regulate those
that EPA determines pose
unreasonable risks to human health or
the environment.
This report describes (1) the extent to
which the IRIS Program has addressed
identified challenges and made
progress toward producing chemical
assessments; and (2) the extent to
which EPA has demonstrated progress
implementing TSCA. GAO reviewed
NAS and EPA documents and
interviewed officials from EPA and
representatives from two
environmental and two industry
stakeholder organizations.
What GAO Recommends
GAO made recommendations
previously to improve the IRIS
Program and TSCA implementation.
EPA provided comments, which
GAO incorporated as appropriate.
Page i GAO-19-270 Chemical Assessments
Letter 1
Background 5
The IRIS Program Has Made Progress in Addressing Identified
Process Challenges, but EPA Leadership Deliberations
Delayed Progress on Producing Assessments 14
EPA Has Demonstrated Progress Implementing TSCA by
Responding to TSCA Statutory Deadlines through the End of
Fiscal Year 2018, but Key Challenges Remain 28
Agency Comments 38
Appendix I Comments from the Environmental Protection Agency 42
Appendix II GAO Contacts and Staff Acknowledgments 48
Related GAO Products 49
Table
Table 1: Selected Provisions of the Toxic Substances Control Act
(TSCA) and Changes based on the Frank R. Lautenberg
Chemical Safety for the 21st Century Act 13
Figures
Figure 1: Risk Assessment Process Used by the Environmental
Protection Agency (EPA) 5
Figure 2: Environmental Protection Agency’s (EPA) Organizational
Structure 7
Figure 3: Environmental Protection Agency’s (EPA) Integrated
Risk Information System (IRIS) Chemical Assessment
Development Process 9
Contents
Page ii GAO-19-270 Chemical Assessments
Abbreviations
EPA Environmental Protection Agency
ETBE ethyl tertiary butyl ether
FTE full-time equivalent
IRIS Integrated Risk Information System
Lautenberg Act Frank R. Lautenberg Chemical Safety for the 21
st
Century Act
NAS National Academy of Sciences
OPPT Office of Pollution Prevention and Toxics
ORD Office of Research and Development
PAH polycyclic aromatic hydrocarbon
PCB polychlorinated biphenyl
PFAS per- and polyfluoroalkyl substance
PFBA perfluorobutanoic acid
PFBS perfluorobutane sulfonic acid
PFDA perfluorodecanoic acid
PFHxA perfluorohexanoic acid
PFHxS perfluorohexane sulfonic
PFNA perfluorononanoic acid
PFOA perfluorooctanoic acid
PFOS perfluorooctane sulfonate
RDX hexahydro-1,3,5-trinitro-1,3,5-triazine
SAB Science Advisory Board
TBA tert-butyl alcohol
This is a work of the U.S. government and is not subject to copyright protection in the
United States. The published product may be reproduced and distributed in its entirety
without further permission from GAO. However, because this work may contain
copyrighted images or other material, permission from the copyright holder may be
necessary if you wish to reproduce this material separately.
Page 1 GAO-19-270 Chemical Assessments
441 G St. N.W.
Washington, DC 20548
March 4, 2019
The Honorable Thomas Carper
Ranking Member
Committee on Environment and Public Works
United States Senate
Dear Senator Carper:
The Environmental Protection Agency (EPA) is responsible for reviewing
the environmental and health effects of chemicals in commerce and
chemicals that have yet to enter commerce. Currently more than 40,000
active chemical substances exist in commerce in the United States, with
more new chemicals submitted to EPA for review every year.
1
Since
June 22, 2016, companies have manufactured more than 550 new
chemical substances that EPA approved for commerce. While chemicals
contribute to virtually every aspect of modern life, exposures to chemicals
can have negative health and environmental consequences. EPAs ability
to effectively implement its mission of protecting public health and the
environment depends on its credible and timely assessments of the risks
posed by chemicals. The agencys Integrated Risk Information System
(IRIS) Program identifies and characterizes the health hazards of
chemicals and produces chemical assessments that contain this
information. Several program and regional offices at EPA use these
chemical assessments in their statutorily mandated risk management
work.
The Toxic Substances Control Act of 1976 (TSCA) provides EPA with the
authority to review chemicals already in commerce (existing chemicals)
and chemicals yet to enter commerce (new chemicals), obtain more
information on the effects of chemicals on human health and the
environment, and regulate those that EPA determines pose unreasonable
risks to human health or the environment. In 2016, Congress enacted the
Frank R. Lautenberg Chemical Safety for the 21st Century Act
(Lautenberg Act), which amended TSCA to expand EPAs authority and
responsibility related to regulating toxic chemicals, and established
1
EPA defines active substanceto generally include, among other things, chemical
substances added to the Toxic Substances Control Act of 1976 (TSCA) Inventory on or
after June 21, 2006. 40 C.F.R. § 710.23. According to EPAs TSCA Inventory, last
updated on February 19, 2019, there were 40,655 active chemical substances.
Letter
Page 2 GAO-19-270 Chemical Assessments
specific deadlines to promulgate new rules, conduct risk evaluations for
existing chemicals, and review and make determinations for new
chemical submissions, among other responsibilities.
The National Academy of Sciences (NAS) and we have made
recommendations on many topics related to IRIS.
2
As part of EPA’s
response to NASs and our recommendations, the IRIS Program began
making changes designed to increase transparency about the program’s
processes and methodologies, increase the use of a systematic review
process,
3
and modernize information collection. In addition, we previously
recommended that EPA develop an agency-wide chemical management
strategy to address the unmet needs of EPA program offices and
regions.
4
In 2009, we also added EPAs process for assessing and
controlling toxic chemicals to our list of agencies and program areas that
are high risk because of their vulnerabilities to fraud, waste, abuse, and
mismanagement or are in most need of transformation.
5
This area was
added to the High-Risk List as a government program in need of broad-
based transformation. While several areas of EPA carry out chemical risk
assessments, this report focuses on the IRIS Program and EPA’s
implementation of TSCA, as amended.
2
National Research Council of the National Academies, Review of EPAs Draft IRIS
Assessment of Formaldehyde (Washington, D.C.: National Academies Press, 2011);
Review of EPAs Integrated Risk Information System (IRIS) Process (Washington, D.C.:
National Academies Press, 2014); and Progress Toward Transforming the Integrated Risk
Information System (IRIS) Program: A 2018 Evaluation (Washington, D.C.: National
Academies Press, 2018). GAO, Chemical Assessments: An Agencywide Strategy May
Help EPA Address Unmet Needs for Integrated Risk Information System Assessments,
GAO-13-369 (Washington, D.C.: May 10, 2013) and High-Risk Series: Progress on Many
High-Risk Areas, While Substantial Efforts Needed on Others, GAO-17-317 (Washington,
D.C.: Feb., 15 2017). See Related GAO Products at the end of this report.
3
Systematic review provides a structured and transparent process for identifying relevant
studies, reviewing their methodological strengths and weaknesses, and integrating these
studies as part of a weight of evidence analysis.
4
GAO-13-369. EPA partially agreed with this recommendation, and as of January 2019, it
remained open.
5
GAO, High-Risk Series: An Update, GAO-09-271 (Washington, D.C.: January 2009). We
added the area because in 2009, actions were needed to streamline and increase the
transparency of IRIS and to enhance EPAs ability under TSCA to obtain health and safety
information from the chemical industry. This high-risk area has evolved since 2009; for
more information, see GAO-17-317. GAO has previously made recommendations aimed
at improving the IRIS Program and TSCA implementation.
Page 3 GAO-19-270 Chemical Assessments
You asked us to examine EPAs chemical management strategies. This
report describes (1) the extent to which the IRIS Program has addressed
identified challenges and made progress toward producing chemical
assessments and (2) the extent to which EPA has demonstrated
progress, if at all, implementing TSCA, and the key challenges that
remain.
To describe the extent to which the IRIS Program has addressed
identified challenges and made progress toward producing chemical
assessments, we interviewed IRIS officials, including leadership and staff,
and leadership in EPA’s National Center for Environmental Assessment,
which manages the IRIS Program. We also interviewed the leadership (as
of September 2018) in EPAs Office of Research and Development
(ORD) and officials from EPA program and regional offices that request or
use IRIS assessments on a regular basis. We interviewed representatives
from an environmental stakeholder organization and an industry
stakeholder organization that have both been involved in chemical
regulatory policy and worked with or followed the IRIS Program for the
past several years, including providing comments to the IRIS Program in
response to a Federal Register notice. We identified these individuals
from our prior work with the IRIS Program. In addition, we obtained
program documentation from 2012 through 2019 from IRIS officials and
through our own searches of EPAs website on changes to IRIS Program
management practices, use of new tools and techniques, and timelines
for the development of chemical assessments. We reviewed applicable
EPA guidelines and program management practices, including the lean
management system being implemented at EPA.
6
We also compared
EPAs actions to establish priorities with federal standards for internal
control.
7
To describe the extent to which EPA has demonstrated progress, if at all,
implementing TSCA, and the key challenges that remain, we interviewed
EPA officials in the Office of Chemical Safety and Pollution Prevention
6
Lean management was developed in the private sector to improve manufacturing
processes, but government has adopted several principles. According to EPAs website,
EPA is initiating the application of lean management principles to identify and eliminate
waste . . . Lean helps organizations improve the speed and quality of their processes by
getting rid of unnecessary activity such as document errors, extra process steps, and
waiting time.
7
GAO, Standards for Internal Control in the Federal Government, GAO-14-704G
(Washington, D.C.: September 2014).
Page 4 GAO-19-270 Chemical Assessments
(OCSPP), the EPA office with primary responsibility for implementing
TSCA, including staff in the Office of Pollution and Preventions (OPPT)
Chemical Control Divisionresponsible for risk managementand staff
in the Risk Assessment Divisionresponsible for risk assessment. In the
Risk Assessment Division, we interviewed five technical teamsworking
groups organized by discipline that bring together experts from across
OPPT branches. To gain perspective from outside stakeholder
organizations with interests in EPAs chemical management strategies, in
addition to the two stakeholder organizations we identified above, we also
interviewed additional representatives from one environmental
stakeholder organization that have followed EPAs implementation of
TSCA and one industry stakeholder organization that represents
companies affected by changes to TSCA. Our interviews with stakeholder
organizations were designed to collect anecdotal information rather than
findings that could be generalized across all possible stakeholder
organizations. We obtained and reviewed documentation from OCSPP
related to its recent activity responding to TSCAs requirements and
conducted our own searches of the Federal Register and EPAs website
to ascertain OCSPPs progress in responding to deadlines. We also
reviewed documentation on previous and proposed budgets and human
resources associated with OPPT and EPAs cost estimates for TSCA
implementation.
We conducted this performance audit from March 2018 to March 2019 in
accordance with generally accepted government auditing standards.
Those standards require that we plan and perform the audit to obtain
sufficient, appropriate evidence to provide a reasonable basis for our
findings and conclusions based on our audit objectives. We believe that
the evidence obtained provides a reasonable basis for our findings and
conclusions based on our audit objectives.
Page 5 GAO-19-270 Chemical Assessments
According to EPA, risk assessments provide information on potential
health or ecological risks.
8
Information from risk assessments, in
combination with other information, provides the basis for risk
management actions, as illustrated in the risk assessment model in figure
1.
Figure 1: Risk Assessment Process Used by the Environmental Protection Agency (EPA)
8
Environmental Protection Agency, Risk Characterization Handbook (Washington, D.C.:
December 2000), January 7, 2019, https://www.epa.gov/sites/production/files/2015-
10/documents/osp_risk_characterization_handbook_2000.pdf.
Background
Risk Assessment and Risk
Management at EPA
Page 6 GAO-19-270 Chemical Assessments
EPA may also consider scientific and economic factors; court decisions;
and social, technological, and political factors during the risk management
process.
A number of program and regional offices at EPA prepare chemical risk
assessments. These risk assessments in turn provide the foundation for
EPAs risk management decisions, such as whether EPA should establish
air and water quality standards to protect the public from exposure to
toxic chemicals. To prepare these risk assessments, some EPA program
and regional offices often rely in part on chemical assessments that the
IRIS Program, as part of ORD, prepares. IRIS assessments generally
include the first two steps of the risk assessment process seen in green in
figure 1: (1) hazard identification and (2) dose-response assessment.
Hazard identification identifies credible health hazards associated with
exposures to a chemical; dose-response assessment characterizes the
quantitative relationship between chemical exposure and each credible
health hazard. The program derives toxicity values through this
quantitative relationship. These toxicity values are combined with
exposure assessments (produced by other offices within EPA) to produce
a risk assessment. OCSPP, which oversees TSCA implementation, also
prepares chemical risk assessments, though it does not generally rely on
IRIS toxicity values. OCSPP’s risk evaluations provide the foundation for
a risk management action under TSCA if a use is found to present
unreasonable risk of injury to human health or the environment. Risk
management actions under TSCA can include but are not limited to
restrictions or bans on a chemical or a condition of use, limitations on
processing or manufacture, or changes to product labeling. Figure 2
shows EPAs organizational structure, including the program and regional
offices that prepare chemical risk assessments.
Page 7 GAO-19-270 Chemical Assessments
Figure 2: Environmental Protection Agencys (EPA) Organizational Structure
Page 8 GAO-19-270 Chemical Assessments
EPA created the IRIS Program in 1985 to help develop consensus
opinions within EPA about the health effects from lifetime exposure to
chemicals. The IRIS database of chemical assessments contains EPA’s
scientific positions on the potential human health effects that may result
from exposure to various chemicals in the environment, and as of
November 2018, it included information on 510 chemicals. Based on our
body of work on the IRIS Program, the programs importance has
increased over time as EPA program offices and regions have
increasingly relied on IRIS chemical assessments in making
environmental protection and risk management decisions. In addition,
state and local environmental programs, as well as some international
regulatory bodies, rely on IRIS chemical assessments in managing their
environmental protection programs. The IRIS Program uses a seven-step
process to produce chemical assessments, as shown in figure 3.
EPAs IRIS Program and
Process
Page 9 GAO-19-270 Chemical Assessments
Figure 3: Environmental Protection Agencys (EPA) Integrated Risk Information System (IRIS) Chemical Assessment
Development Process
The first step in the assessment development process is developing a
draft assessment. This begins with IRIS Program staff determining the
scope and initial problem formulation of an assessment in consultation
with EPA program and regional offices. This information is documented in
an IRIS Assessment Plan and released for agency and public comment.
After obtaining feedback on the IRIS Assessment Plan, IRIS Program
staff prepare an assessment protocol for public comment that describes
the methods that IRIS will use to conduct the assessment. During Step 1
(Scoping and Problem Formulation) IRIS Program staff conduct
preliminary searches of scientific literature and screen relevant studies to
understand the extent and nature of the available evidence. This informs
the level of effort, identifies areas of scientific complexity, and helps the
Page 10 GAO-19-270 Chemical Assessments
IRIS Program estimate time frames for conducting the assessment. The
program staff select and extract relevant data and analyze and integrate
the evidence into the draft assessment. The final step in preparing the
draft assessment is deriving chemical toxicity values. After these draft
development steps (step 1 in fig. 3), the draft assessment goes through
internal agency and interagency review, public comment, and peer
review, as shown in steps 2 through 4 in figure 3. After making revisions
to address comments received (step 5), the assessment goes through
another round of internal and interagency review (steps 6a and 6b), and
then the program finalizes and posts the assessment to the IRIS
website.
9
According to IRIS officials, in order to prepare IRIS assessments, a group
of staff with specialized skills are required. On any given assessment,
approximately a dozen staff drawn from several different backgrounds
(e.g., toxicologists and epidemiologists) work on each assessment. While
some of the assessment preparationthat is, setting up database
searches and performing initial search screeningscan be performed by
any staff, other parts of assessment development require that the staff
have specific expertise.
The IRIS assessment development processand the associated
implementation of systematic review processeshas continued to evolve
since 2011, primarily as a result of NAS recommendations made in two
reports issued in 2011 and 2014. The 2011 report was a NAS peer review
of the IRIS assessment of formaldehyde.
10
In that report, NAS
recommended several changes to the formaldehyde assessment and
also offered recommendations more generally about the IRIS assessment
development process. For example, NAS recommended methods for
identifying evidence to be included in IRIS assessments; assessing and
weighting that evidence in preparing the assessment; selecting studies
that are used for calculating toxicity; and documenting how those toxicity
9
The IRIS Program has not changed the process steps presented in figure 3 since 2013,
but the types of documents produced during step 1scoping and problem formulation
have evolved from preliminary assessment materials (before 2017) to IRIS Assessment
Plans and protocols (after 2017) to better integrate systematic review approaches into the
existing process.
10
Formaldehydeone of the most widely produced chemicals in the worldis used in
many products, including disinfectants, pressed-wood, and clothing and other textiles.
Exposure to this chemical, which has been linked to adverse health effects for more than
30 years, typically occurs through inhalation and dermal (skin) contact.
Page 11 GAO-19-270 Chemical Assessments
calculations are carried out. A House appropriations committee report for
fiscal year 2015 directed EPA to implement the 2011 report’s
recommendations and NAS to review the changes that EPA was making
(or proposing to make). In its review, NAS made additional
recommendations to the program. In April 2018, NAS released a report
on the IRIS Programs responses to the 2014 recommendations.
11
IRIS assessments are one potential source of information for risk
assessors in OCSPP who conduct risk evaluations informing risk
management activities under TSCA. The purpose of risk evaluation is to
determine whether a chemical substance presents an unreasonable risk
to human health or the environment.
TSCA authorizes EPA to evaluate and, if appropriate, regulate existing
chemicals and new chemicals. TSCA generally covers chemicals
manufactured, imported, processed, distributed in commerce, used, or
disposed of in the United States. If EPA finds that any of these activities
with respect to a specific chemical presents an unreasonable risk of injury
to health or the environment, EPA must issue regulations that can, among
other things, restrict or prohibit these activities.
12
TSCA also specifies the information obtained from chemical companies
that EPA must publicly disclose and the circumstances under which
chemical companies can claim certain information, such as data about
chemical processes, as confidential business information. EPAs OPPT
within the Office of Chemical Safety and Pollution Prevention manages
risk assessment and risk management strategies for chemicals under
TSCA. According to EPA officials, OPPTs Risk Assessment Division
11
NAS made 38 specific recommendations to the IRIS Program about processes in its
2014 report and provided an update on the programs progress in implementing them in its
2018 IRIS Program evaluation. See Appendix E in National Academies of Sciences,
Engineering, and Medicine Progress Toward Transforming the Integrated Risk Information
System (IRIS) Program: A 2018 Evaluation (National Academies Press, Washington,
D.C., 2018).
12
The unreasonable risk of injurystandard differs from those under other environmental
laws, such as those under the Clean Air Act and Clean Water Act, which require EPA to
limit pollutant emissions to levels that are technologically achievable. See 42 U.S.C. §
7412(d)(2) (EPA must establish Clean Air Act standards that require the maximum degree
of reduction in emissions of the hazardous air pollutants achievable for new or existing
sources in the category or subcategory to which such emission standard applies); 33
U.S.C. § 1314(b) (EPA must establish technology-based effluent limitation guidelines
under the Clean Water Act).
EPAs Evaluation and
under TSCA
Page 12 GAO-19-270 Chemical Assessments
uses a number of different streams of informationincluding IRIS
assessments—to prepare chemical risk assessments in order to make
determinations about the safety of chemicals, and the Chemical Control
Division uses those risk assessments to prepare risk management plans
for chemicals.
Prior to 2016, environmental and industry stakeholder organizations
expressed concern that public confidence was decreasing regarding the
safe use of chemicals in commerce and that federal oversight should be
strengthened. For example, according to an American Bar Association
new TSCA guide,
13
the desire for reform was driven by a proliferation of
state-based chemical initiatives threatening to disturb interstate
commercial transactions and by a continuing erosion of public confidence
in TSCAs ability to protect human health and the environment from
unreasonable risks presented by chemicals. In addition, according to a
statement from the Environmental Defense Fund, federal oversight could
not keep pace with science or rapidly expanding production and use of
chemicals.
In June 2016, Congress passed the Lautenberg Act, which amended
TSCA in several ways. Table 1 summarizes some of the major changes
in the act, along with the purpose and application of TSCAs major
sections.
13
Lynn Bergeson and Charles Auer, New TSCA: A Guide to the Lautenberg Chemical
Safety Act and Its Implementation (American Bar Association, 2017), xvii-xviii.
Page 13 GAO-19-270 Chemical Assessments
Table 1: Selected Provisions of the Toxic Substances Control Act (TSCA) and Changes based on the Frank R. Lautenberg
Chemical Safety for the 21st Century Act
Section of TSCA
Topic
Lautenberg Act changes
4 - Chemical testing
Authorizes the Environmental
Protection Agency (EPA) to issue
regulations requiring companies to
test chemicals to develop
information with respect to their
health and environmental effects if
EPA finds that the chemical may
present an unreasonable risk.
Authorizes EPA to require chemical testing for certain
purposes by order or consent agreement in addition to by
rule, without a prior finding of risk.
5 - New chemical substance and
significant new use notices
Requires manufacturers to provide
notice for new chemical substances
and significant new uses. Under the
original law, manufacture could
generally occur 90 days after
submission.
Requires EPA to make a determination within 90 days of
application submission as to whether regulatory action is
warranted before a new chemical, or a chemical for a use
that is a significant new use, can be manufactured or
processed.
6 - Chemical regulation
Authorizes EPA to regulate
chemicals by, among other things,
banning or restricting their
manufacture.
Requires EPA to establish by rule a new risk-based
process for prioritizing, evaluating, and regulating
chemical risks and establishes relevant deadlines.
8 - Reporting and retention of
chemical information (TSCA
Inventory)
Directs EPA to promulgate rules
regarding recordkeeping and
reporting of certain chemical
information, such as on exposure
and environmental and health
effects.
Establishes a process under which EPA is to require
chemical manufacturers to update EPA regarding which
chemicals on the TSCA Inventory were manufactured or
processed during the 10-year period before the
enactment of the Lautenberg Act (from June 2006
through June 2016) and, as appropriate, substantiate
claims of confidentiality regarding chemical identity
pursuant to section 14.
14 - Confidentiality and disclosure of
information
Sets forth the circumstances under
which the disclosure of information
provided to or obtained by EPA
under TSCA is required, permitted,
or prohibited.
Establishes new substantiation requirements for
confidentiality claims regarding a specific chemical
identity and new circumstances under which information
is to be disclosed, including in certain situations to states
and human health or environmental professionals.
18 - Preemption of state
requirements
Describes the circumstances where
states are prohibited from
establishing and enforcing chemical
regulations.
Defines the types of state actions that are and are not
generally preempted by TSCA, and authorizes EPA to
grant waivers under certain circumstances.
26 - Administration of TSCA,
including fees
Authorizes EPA to collect fees for
submission of certain information.
Establishes a TSCA Service Fee fund under which fees
assessed by EPA for submission of notices and other
information under section 5 and for risk evaluation are to
be deposited. Provides that EPA can retain and use the
fees collected for certain specified purposes. Requires
EPA, in carrying out sections 4, 5, and 6, to use scientific
information and methods in a manner consistent with the
best available science.
Source: GAO analysis of TSCA and the Lautenberg Act. | GAO-19-270
Page 14 GAO-19-270 Chemical Assessments
Since passage of the Lautenberg Act, several areas of disagreement
have arisen among stakeholders regarding the implementation of various
aspects of the act. One of the main points of ongoing discussion centers
on what conditions of use EPA must consider in a chemical risk
evaluation under TSCA. EPA and some stakeholders also disagree on
other areas such as the methodologies EPA uses in its systematic review
approach, the extent to which companiesdata are exempt from
disclosure, and the extent to which the fees rule accurately reflects EPA’s
costs for implementing TSCA. Some of these issues have resulted in
litigation.
The IRIS Program has addressed many process challenges, such as by
making changes to address the length of time it takes to develop
chemical assessments and to increase transparency, but EPA has not
made progress toward producing chemical assessments. However, the
release of documents related to IRIS assessments was delayed for nearly
6 months because EPA leadership instructed the IRIS Program not to
release any assessment documentation pending the outcome of EPA
leadership deliberations concerning IRIS Program priorities.
The IRIS Program in 2011 began making changes to address identified
challenges, particularly the length of time the program took to produce
assessments and the level of transparency in how the program prepared
assessments. The program has made some progress since the beginning
of 2017 toward producing assessments and is ready to release
assessment-related documents. These changes were made in response
to program implementation challenges identified by governmental,
The IRIS Program
Has Made Progress
in Addressing
Identified Process
Challenges, but EPA
Leadership
Deliberations Delayed
Progress on
Producing
Assessments
The IRIS Program Has
Made Progress in
Addressing Identified
Challenges
Page 15 GAO-19-270 Chemical Assessments
industry, academic, and non-governmental stakeholders in recent years.
14
For example, in its 2011 report, NAS identified timeliness and
transparency as issues.
15
In our review of the 2011 and 2014 NAS reports
and other documentation as well as our interviews with IRIS officials and
leadership and officials in program and regional offices that use IRIS
assessments, we identified the key actions the IRIS Program has taken to
address lack of timeliness in producing assessments and lack of
transparency in how it produces assessments.
Developing IRIS assessments has historically been a lengthy process.
Because of the rigor of the IRIS process and the amount of literature that
program staff must search and consider, producing an assessment
typically takes several years, as we found in December 2011.
16
Program
and regional offices that use IRIS assessments understand this, and
officials from several program and regional offices told us that despite the
length of time it takes for the IRIS Program to complete its assessments,
they prefer these assessments as sources of information over other
agenciestoxicity assessments.
To address the length of time it takes to produce assessments, the IRIS
Program is (1) employing project management principles and specialized
software that enable the program to better plan assessment schedules
and utilize staff to make the systematic review process more efficient; (2)
focusing on better scoping assessments to create timely, fit-for-purpose
14
National Research Council of the National Academies, Review of EPAs Draft IRIS
Assessment of Formaldehyde (Washington, D.C.: National Academies Press, 2011);
Review of EPAs Integrated Risk Information System (IRIS) Process (National Academies
Press, Washington, D.C., 2014); Progress Toward Transforming the Integrated Risk
Information System (IRIS) Program: A 2018 Evaluation (Washington, D.C.: National
Academies Press, 2018). GAO, Chemical Assessments: Low Productivity and New
Interagency Review Process Limit the Usefulness and Credibility of EPAs Integrated Risk
Information System, GAO-08-440 (Washington, D.C.: Mar. 7, 2008; Chemical
Assessments: Challenges Remain with EPAs Integrated Risk Information System
Program, GAO-12-42 (Washington, D.C.: Dec. 9, 2011); GAO-13-369; and GAO-17-317.
Making EPA Great Again, Before the H.R. Comm. On Science, Space and Technology,
115th Cong, (2017) (Statement of Kimberly W. White, Ph.D., American Chemistry
Council).
15
Subsequent NAS reports re-iterated these recommendations but also commended the
program for the progress it made in implementing changes in response to
recommendations. See NASs Review of EPAs Integrated Risk Information System (IRIS)
Process and Progress Toward Transforming the Integrated Risk Information System
(IRIS) Program: A 2018 Evaluation.
16
GAO-12-42.
The IRIS Program Has Made
Changes to Address
Timeliness
Page 16 GAO-19-270 Chemical Assessments
products that address specific agency needs;
17
and (3) streamlining the
peer review process as much as possible.
The Program Has Adopted Project Management Principles and New
Software
The first way in which the IRIS Program is addressing the length of time it
takes to produce assessments is by utilizing project management
principles and new software that enable the program to better plan
assessment schedules and utilize staff. IRIS officials said that by using
these tools, IRIS staff are able to view project tasks, timelines, and
milestones to manage their individual tasks and assessment work. For
example, IRIS officials said that as part of an EPA-wide initiative, they
began incorporating lean management techniques, which aim to improve
efficiency and effectiveness by reducing unnecessary process steps and
waiting time. Additionally, IRIS officials said that they have begun using a
staffing model that trains staff to be proficient in all phases of the
systematic review process (i.e., screening, data extraction, study
evaluation, and evidence synthesis). This modularity will make it easier
for staff to work across teams and on multiple projects, assisting with
systematic review needs while also contributing in their areas of
expertise, according to IRIS Program officials. In addition, the IRIS
Program began using both project management software and business
intelligence and visualization software in 2017. IRIS Program leadership
is using this software to generate resource allocation reports showing
staff assignments, enabling leadership to better manage staff workloads.
According to IRIS officials, the recent adoption of specialized systematic
review software also enables program staff to perform more literature
searches faster, and the ability to filter search results allows staff to find
more quickly the most relevant information for an assessment. Use of
software tools with machine-learning capabilities facilitate program staffs
ability to screen studies for relevance more quickly compared to
approaches used before 2017. Prior to the adoption of these specialized
software tools, much of the development of an assessment was manual
(i.e., using a spreadsheet). For example, for one assessment developed
manually, contactors working on an IRIS assessment took over 200 hours
to screen and catalog 1,200 epidemiological studies, including carrying
out quality assurance checks. By comparison, using machine-learning
17
Fit-for-purpose assessments are more limited in scope and targeted to a specific
requesters need, rather than encompassing all possible information about a chemical.
Page 17 GAO-19-270 Chemical Assessments
tools, EPA staff were able to screen almost 5,500 articles in about 30
hours. With the new tools, quality assurance was embedded into the
workflow by having two independent reviewers and a software-facilitated
process track and resolve screening conflicts.
Additionally, an official from EPAs National Health and Environmental
Effects Research Laboratory said that the laboratory uses a similar
screening process. The laboratory worked with the IRIS Program to
identify similar constructs in their processes and used each others results
to make changes and validate tools used by both. According to IRIS
officials, as a result, the use of these tools has created more efficient
workflow processes, leading to considerable cost and time savings. The
incorporation of systematic review software tools has greatly helped the
program more efficiently carry out tasks like screening literature,
evaluating study quality, extracting data, and developing visualizations,
according to IRIS Program officials we interviewed. Most importantly, the
software tools allow multiple staff members to work on tasks
simultaneously, rather than one at a time, facilitating concurrent
completion of key assessment pieces.
The Program Tailors Assessments to Program and Regional Office
Needs
The second way in which the IRIS Program is reducing the length of time
it takes to produce assessments is by tailoring them to program and
regional office needs, called fit-for-purpose assessments. According to
IRIS officials, part of the reason assessments historically were time-
consuming was because the program tried to synthesize and present all
possible information on the human health effects of a particular chemical,
including multiple exposure pathways (e.g., inhalation, ingestion, or
dermal) and reference doses, reference concentrations, and cancerous
and non-cancerous effects.
18
This required large amounts of data
18
According to IRIS Program information, reference concentrations are an estimate of a
continuous inhalation exposure to the human population that is likely to be without an
appreciable risk of harmful effects during a lifetime. Reference doses are an estimate of a
daily oral exposure to the human population that is likely to be without an appreciable risk
of harmful effects during a lifetime. Cancer descriptors characterize a chemical as:
carcinogenic to humans,” “likely to be carcinogenic to humans,” “suggestive evidence of
carcinogenic potential,inadequate information to assess carcinogenic potential,” or “not
likely to be carcinogenic to humans.While the TSCA program makes use of some of the
information contained in IRIS assessments, it generally does not use these IRIS endpoint
values.
Page 18 GAO-19-270 Chemical Assessments
extraction and was very time intensive. Beginning in early 2017, the
program began implementing the fit-for-purpose approach to producing
assessments. IRIS officials said the idea is that instead of producing a
wide-ranging assessment, the program can produce assessments that
are more limited in scope and targeted to specific program and regional
office needs, reducing the amount of time IRIS staff needed to search for
information, synthesize it and draft, review, and issue an assessment. For
example, if the Office of Air and Radiation needed a chemical
assessment that examined only inhalation exposures, the IRIS Program
could limit its assessment to a single exposure pathway, which would
reduce the amount of data that staff review and extract and, with less text
to draft and less complex peer reviews, allow the assessment to more
quickly move through the process.
IRIS officials said that if offices make subsequent requests for other
effects or exposure pathways, the IRIS Program can update the original
assessment. IRIS officials said that they expect time savings as a result
of moving to the fit-for-purpose model. As of November 1, 2018, the IRIS
Program had produced two fit-for-purpose assessments: a request for
correction on chloroprene and an update of the assessment on acrolein.
An assessment on perfluorobutane sulfonic acid (PFBS) was also
released for public comment following peer review.
19
PFBS are a member
of a class of man-made chemicals known as per- and polyfluoroalkyl
substances (PFAS)a groups that also includes perfluorooctane
sulfonate acid (PFOS), perfluorooctanoic acid (PFOA), GenX, and many
others. In addition, since 2017, the IRIS Program released scoping and
problem formulation materials for six IRIS chemical assessments
19
The chloroprene correction took approximately 7 months to complete, and the update of
the acrolein assessment took approximately 4 months to produce and will be ready to be
released for review pending the results of EPA leadership deliberations. The assessment
on PFBS took approximately 9 months to produce and was ready to be released for public
comment as of October 2018. Chloroprene is a flammable liquid used to make rubber;
acrolein is a liquid used as a pesticide and to make other chemicals, and PFBS is a
compound used to make various consumer products.
Page 19 GAO-19-270 Chemical Assessments
(nitrates/nitrites, chloroform, ethylbenzene, uranium, ammonia, and
naphthalene).
20
Additionally, the program is examining ways to assist program and
regional offices with information that may not necessitate developing a full
assessment. For example, the Office of Air and Radiation was doing work
using a toxicity value for acrolein that the California Environmental
Protection Agency prepared in 2008, because that value was more recent
than the value in the IRIS database. However, a large number of studies
on acrolein had been released since 2008, so the IRIS Program searched
approximately 10,000 new studies and concluded that the study used by
California Environmental Protection Agency in 2008 was still the most
appropriate study for chronic toxicity value derivation. In addition, IRIS
staff developed an updated draft reference concentration for acrolein
based on this study. The screening and update process took
approximately 4 months, demonstrating how the IRIS Programs use of
new tools and a targeted scope resulted in more timely attention to
program office needs.
The Program Is Streamlining the Peer Review Process
The third way the IRIS Program is addressing the length of time it takes to
produce assessments is by streamlining the peer review process as much
as possible without compromising the quality of the review. EPA
guidelines require peer review of all IRIS assessments. Smaller, less
complex assessments may be peer reviewed through a contractor-led
letter review or panel; more complex assessments are usually reviewed
by a full Scientific Advisory Board (SAB) or a NAS panel, though IRIS
leadership determines the most appropriate method of peer review based
on Office of Management and Budget and EPA Peer Review Handbook
guidelines. While the contractor-led letter or panel reviews are no less
robust than full SAB or NAS panel reviews, the contractor-led reviews are
usually smaller and completed in less time because they are reviewing
smaller, less complex IRIS assessments. The time savings occur
because the reviewers do not typically meet in person, or may meet only
20
Nitrates/nitrites are naturally occurring ionic species used in inorganic fertilizers.
Chloroform is a colorless liquid used to make other chemicals. Ethylbenzene is a
colorless, flammable liquid found in natural products and manufactured products such as
ink, insecticides, and paints. Uranium is a naturally occurring and radioactive substance.
Ammonia is a colorless gas used in cleaning products and fertilizers. Naphthalene is a
white solid used in the manufacture of plastics, moth repellents, and toilet deodorant
blocks.
Page 20 GAO-19-270 Chemical Assessments
once, typically taking a few months to complete their reviews. In contrast,
SAB and NAS panels involve larger numbers of people who meet multiple
times, review longer and more complex assessments, and must reach
consensus on their reviews. As a result, SAB and NAS peer reviews can
take more than a year to complete. IRIS officials said that as they try to
produce more fit-for-purpose assessments that are smaller in scope, they
plan to utilize letter reviews as appropriate, to streamline the peer review
process. IRIS Program officials said they also hope that other changes
they recently implementedprimarily, increased transparency and
systematic reviewwill help speed up the peer review process by
producing a higher-quality overall draft.
Another major category of NAS recommendations that the IRIS Program
has addressed is the need for greater transparency in how the program
conducts assessments. For example, one industry representative
expressed concern in August 2018 about transparency before the
program began making changes, describing the IRIS Program as a black
boxbecause no one knew how the program created its methodologies,
weighted evidence, or produced assessments.In response, the IRIS
Program has in the past several years (1) implemented systematic
review, which provides a structured and transparent process for
identifying relevant studies, reviewing their methodological strengths and
weaknesses, and integrating these studies as part of a weight of evidence
analysis, and (2) increased outreach efforts with stakeholders and the
public, both in terms of the frequency and the depth of content about
assessment preparation.
The Program Began Implementing Systematic Review as a Basis of
Its Assessments
The IRIS Program began addressing the need for greater transparency
by implementing systematic review as a basis for every assessment and
has been doing so for several years. A systematic review is a structured
and documented process for transparent literature review. It is a scientific
investigation that focuses on a specific question and uses explicit,
prespecified scientific methods to identify, select, assess, and summarize
the findings of similar but separate studies. The goal of systematic review
methods is to ensure that the review is complete, unbiased, reproducible,
and transparent. By using systematic review, the IRIS Program can
demonstrate that it considered all available literature in forming
conclusions and deriving toxicity values. Utilizing the new software tools
described above allows program staff to search more widely than before
and to identify the most relevant results faster and more accurately. The
The IRIS Program Has Made
Changes to Address Lack of
Transparency
Page 21 GAO-19-270 Chemical Assessments
IRIS Program is working with technical experts to increase the
applications of machine learning for carrying out systematic review.
Additionally, new software allows the IRIS Program to save and publish
its search strings and to indicate why it selected certain studies over
others for review and inclusion. The software also allows multiple staff to
check searches and concur or not-concur with the initial assessment
about including a scientific article in the draft assessment. IRIS officials
told us that the transparency associated with systematic review and
clearer explanation of methodologies in assessments (as well as
releasing subsidiary documents, such as IRIS Assessment Plans and
Assessment Protocols) will improve stakeholdersunderstanding of how
the program arrives at its conclusions.
The Program Has Made Changes to Communication Frequency and
Type
The IRIS Program also furthered transparency by increasing the
frequency, structure, and content of communications with EPA program
and regional offices about overall program priorities and individual
assessments. This allows EPA program and regional offices to know
when to expect assessments, as well as what those assessments will
cover. To prepare the 2015 Multi-Year Agenda, the IRIS Program
solicited requests from EPA program and regional offices about which
chemical assessments they needed; these requests were released in
December 2015.
21
When new leadership joined the IRIS Program in early
2017, the new officials began reaching out to individual program and
regional offices to re-confirm their needs and priorities. IRIS officials said
this effort was in part to ensure that the IRIS Program was delivering what
the program offices needed, as well as to help the IRIS Program keep its
priorities up to date and ensure that resources (primarily staff) were
aligned with EPA-wide priorities. Based on these conversations with
program and regional office staff, the IRIS Program made some chemical
assessments higher priority and removed others from the programs
workflow, consistent with stated needs.
In May 2018, the IRIS Program prepared a statement for posting on the
IRIS website outlining these changes to the programs workflow and an
updated list of assessments that were being developed with anticipated
21
The IRIS Multi-Year Agenda identifies the top priority chemical assessments for which
the IRIS Program will develop assessments in the next few years.
Page 22 GAO-19-270 Chemical Assessments
completion time frames. However, EPA leadership in ORDthe office
that oversees the IRIS Programdid not approve this statement for
release because current EPA leadership in program and regional offices
had not formally requested these assessments. Nevertheless, officials
from program and regional offices that use IRIS assessments told us that
they received clear communication from the IRIS Program about priorities
and timelines for individual assessments. According to these officials,
some of this communication took place when IRIS Program leadership
reached out to program and regional office officials to confirm their needs,
and some took place during monthly telephone calls the IRIS Program
held to update stakeholders on assessment development timelines.
Program and regional office officials told us that they appreciated the IRIS
Programs recent efforts to understand program and regional office needs
and timelines; communicate the status of assessments more frequently;
and find ways to assist program offices that may not require developing a
full assessment, such as assessment updates or literature reviews.
Since 2013, the IRIS Program has released preliminary assessment
materialsincluding IRIS Assessment Plans and assessment protocols
so that EPA and interagency stakeholders and the public could be aware
of scoping and problem formulation for each assessment. Since 2017,
according to EPA, these documents had a new structure and better
demonstrate the application of systematic review, and they continue to
convey EPAs need for each assessment and frame questions specific to
each assessment. Officials in several program and regional offices that
use IRIS assessments told us that the release of IRIS Assessment Plans
and protocols was very helpful because it allowed them to offer early
input to the IRIS Program about the scope of an assessment, when it
could affect the direction of the assessment. IRIS officials also said that
they created templates for several parts of the assessment process,
including the IRIS Assessment Plans and assessment protocols, which
help maintain consistency throughout assessment development and from
one assessment to the next.
During calendar year 2018, the IRIS Program planned to release
documents or hold meetings for 15 of the 23 ongoing chemical
assessments in development, as well as for the IRIS Handbook and a
template for assessment protocols. From January through May 2018, the
IRIS Program met each of its internal deadlines for work on 9 different
chemical assessments and released the template for assessment
protocols for agency review. The IRIS Program also produced a report to
Congress on the programs work in January 2018 and took part in a NAS
The Program Made
Progress in Early 2018 on
Assessments in
Development
Page 23 GAO-19-270 Chemical Assessments
review of the program in February 2018. The NAS review, which offered a
third-party assessment of the programs efforts, provided a supportive
assessment of ongoing transformations aimed at ensuring data quality,
new systematic approaches for data analysis and expanded stakeholder
engagement efforts, and increased the efficiency of assessments.
According to the report, NAS reviewers were impressed with the changes
being instituted in the IRIS Program since 2014, including substantive
reforms by new IRIS Program leadership, such as the development,
implementation, and use of systematic review methods to conduct IRIS
assessments. In addition, as of August 2018, the final IRIS assessment of
hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) was issued.
22
In early
November 2018, IRIS officials told us that the agency had almost
completed internal review of the handbook, which was being prepared for
public release. In December 2018, the IRIS Program and OPPT
participated in a NAS workshop that informed the systematic review of
mechanistic evidence.
23
The IRIS Program has made important changes aimed at producing more
timely and transparent assessments, but IRIS officials told us that
proposed budget cuts have caused them concern about whether they will
have sufficient resources to expand assessment work in the future. The
human health risk assessment area, of which IRISs budget makes up
approximately half, has been funded at about $38 million annually since
fiscal year 2013 based on our review of EPA budget documents.
However, the Presidents budget request for human health risk
assessment work in fiscal years 2018 and 2019 was $22.5 million and
$22.2 million, respectively. This represents a cut of approximately $17
million from previous budget levels dating back to fiscal year 2013. The
IRIS Program budget would drop approximately 40 percent from $20.8
million to approximately $12 million if these cuts were enacted. Congress
did not support these reductions. Specifically, according to the joint
explanatory statements accompanying the Consolidated Appropriations
Act, 2018, and Consolidated Appropriations Act, 2019, Congress had
agreed to continue providing funding at fiscal year 2017 enacted levels.
Cuts to the program could impact EPAs regulatory work: Officials in
22
RDX is a highly powerful explosive used by the U.S. military in thousands of munitions.
23
On December 10 and 11, 2018 the National Academies of Sciences, Engineering, and
Medicine held a workshop on current state-of-the-art in performing systematic reviews of
mechanistic data to support chemical assessments. http://dels.nas.edu/Upcoming-
Workshop/Strategies-Tools-Conducting-Systematic/AUTO-5-32-82-N.
Budget Cuts May Impact
the Programs Ability to
Expand Assessment
Development
Page 24 GAO-19-270 Chemical Assessments
almost all of the program and regional offices that use IRIS assessments
told us that they rely on IRIS assessments to do their workit is the first
place they look for chemical toxicity values, and if the IRIS Program is
unable to produce assessments, their offices would be challenged to
meet statutory deadlines and there would be a generally negative effect
on public health.
The IRIS Program made progress developing assessments and
producing assessment documentation (e.g., IRIS Assessment Plans and
protocols) in early 2018. However, EPA leadership deliberations about
the programs priorities that took place from June through December
2018 delayed the programs assessment production.
IRIS officials told us that in early June 2018 EPA leadership in ORD
informed them that the IRIS Program could not release an assessment
without a formal request for that assessment from the current leadership
of a program office.
24
At the request of the Administrator, IRIS officials
prepared a survey of program and regional offices, asking them to re-
confirm their needs for 20 assessments that were in development.
25
This
survey was sent by memorandum in August 2018. Program office
responses were to be signed by the Assistant Administrator of each
program office to ensure that the re-confirmations were consistent with
the priorities of EPA program office leadership.
26
While survey responses
were being compiled, EPA leadership in ORD instructed the IRIS
Program not to publically release any assessment documentation. As a
result, any assessment or subsidiary assessment document (e.g., an IRIS
Assessment Plan or protocol) that was ready for agency review, public
24
This included any associated parts of an assessment, such as Assessment Plans or
protocols. For example, IRIS officials said that the IRIS Assessment Plan for naphthalene
had been ready for release since May 25, 2018, but EPA leadership in ORD refused to
sign off on the release because no other EPA leadership in program offices had formally
requested the assessment. The IRIS Assessment Plan for naphthalene was eventually
released for public comment on July 5, 2018, but the public meeting to discuss the
naphthalene IRIS Assessment Plan that was scheduled for August 23, 2018, was
postponed the day before that meeting with no explanation and no makeup date.
25
The survey did not include two assessments, ethyl tertiary butyl ether (ETBE) and tert-
butyl alcohol (TBA), because they were out for public comment and external peer review.
26
Regional offices were told that their submissions would be included as part of a program
office request.
IRIS Program Progress
toward Producing
Assessments Was
Delayed by EPA
Leadership Deliberations
about Priorities
Page 25 GAO-19-270 Chemical Assessments
comment, or peer review was unable to proceed through the IRIS
assessment development process.
In late October 2018, prior to releasing results of the initial program and
regional office survey, EPA leadership in ORD made a second request of
program offices for a prioritized list of assessments. According to officials
from the IRIS office, who were queried for advice by officials from some
program offices, ORD’s second request was made verbally at a meeting
and included direction to the program offices to limit their requests to no
more than three to four chemicals. ORD’s request did not provide
information on the basis for selecting priorities or the reason for the limit
of three or four chemical assessments from the original survey
submissions. The calls for advice from program office officials
represented the first time the IRIS Program heard about the requests for
a prioritized list, according to IRIS program officials. And since neither the
program and regional offices nor the IRIS Program had information from
the Administrator’s office about what the prioritization was meant to
achieve, the IRIS Program was unable to provide guidance about what
chemicals might be considered a priority, or how many they might be able
to continue work on.
When EPA leadership’s deliberations about the program’s priorities were
completed, a memorandum was issued on December 4, 2018, that listed
11 chemical assessments that the IRIS Program would develop. This was
a reduction of the programs workflow from 22 assessments, but the
memorandum announcing the reduced workflow gave no reason for the
reduction. The memorandum accompanying the list of 11 chemicals gave
no indication of when more assessments could be requested or if IRIS’s
workflow would remain at 11 chemicals for the foreseeable future.
According to the memorandum, the 11 chemicals were requested by two
EPA program offices (the Office of Water and the Office of Land and
Emergency Management). We received this memorandum at the end of
our review and did not have the opportunity to review the prioritization
process that led to its drafting.
Two weeks after the issuance of the memorandum, the IRIS program
publicly issued an outlook of program activities, which included two
additional assessments that were not included in the memorandum.
These two assessments, ethyl tertiary butyl ether (ETBE) and tert-butyl
alcohol (TBA), were not included in the memorandum because they were
out for public comment and external peer review. Furthermore, four
assessments that were in the later stages of development and had not
been issued were not included in the December 2018 Outlook. The four
Page 26 GAO-19-270 Chemical Assessments
assessments were: acrylonitrile, n-Butyl alcohol, formaldehyde,
27
and
polycyclic aromatic hydrocarbon (PAH). The assessment of formaldehyde
was, according to the “IRIS Assessments in Development” website, at
Step 4 of the IRIS process (an assessment is drafted and was ready to be
released for public comment and external peer review). The absence of
these four assessments from the December 2018 Outlook could create
confusion for stakeholders interested in them. EPA provided no
information on the status of these four assessments or whether it planned
to discontinue working on them or restart them at another time. As we
have previously reported, an overarching factor that affects EPAs ability
to complete IRIS assessments in a timely manner is that once a delay in
the assessment process occurs, work that has been completed can
become outdated, necessitating rework throughout some or all of the
assessment process.
28
Thus, it remains to be seen when these
assessments can be expected to move to the next step in the IRIS
process or be completed.
As of December 19, 2018, the status of the 13 assessments in the
December 2018 Outlook was:
External peer review: ETBE and TBA.
29
Draft Development: arsenic, inorganic; chromium VI; polychlorinated
biphenyls (PCBs; noncancer); perfluorononanoic acid (PFNA);
perfluorobutanoic acid (PFBA); perfluorohexanoic acid (PFHxA);
perfluorohexane sulfonate (PFHxS); and perfluorodecanoic acid
(PFDA).
30
27
As we have previously reported, EPA began an IRIS assessment of formaldehyde in
1997 because the existing assessment was determined to be outdated. Formaldehyde is
a colorless, flammable, strong-smelling gas used to manufacture building materials, such
as pressed wood products, and used in many household products, including paper,
pharmaceuticals, and leather goods. GAO-08-440.
28
GAO-08-440.
29
As of February 27, 2019, the external peer review reports for ETBE and TBA were
publicly released.
https://yosemite.epa.gov/sab/sabproduct.nsf/1BC795C095943F25852583AE00659299/$F
ile/EPA-SAB-19-001%20.pdf.
30
PFNA, PFBA, PFHxA, PFHxS and PFDA are members of a class of man-made
chemicals known as PFASa groups that also includes PFOS, PFOA, GenX, and many
others.
Page 27 GAO-19-270 Chemical Assessments
Scoping and Problem Formulation: mercury salts; methylmercury;
vanadium and compounds.
31
According to IRIS officials, the IRIS Program was unable to release any
work since June 2018, while it was waiting for feedback from the
Administrator’s office regarding whether its assessment workflow was
consistent with agency priorities. IRIS officials told us that staff continued
whatever draft development work that they could do internally, but several
IRIS staff have been working increasingly for OPPT to support its work
preparing risk evaluations under TSCA. ORD reported to us that in
September 20183 months after IRIS assessments were stopped from
being released because of ongoing EPA leadership deliberations5 of
approximately 30 IRIS staff were supporting OPPT with 25 to 50 percent
of their time. In October 20184 months after IRIS assessments were
stopped from being released28 of approximately 30 IRIS staff were
supporting OPPT with 25 to 50 percent of their time. According to IRIS
officials, this was occurring primarily because OPPT has a significant
amount of work to do to meet its statutory deadlines, and OPPT needed
IRIS staff expertise to help meet those deadlines. As noted above, TSCA
establishes a regulatory standard that generally differs from those under
other environmental laws, so the TSCA assessments will not necessarily
be relevant to other EPA programs that have relied on IRIS endpoint
values in making their regulatory decisions.
31
For more information on the assessments released in the IRIS 2018 IRIS Program
Outlook, see: https://www.epa.gov/iris/iris-program-outlook.
Page 28 GAO-19-270 Chemical Assessments
EPA has demonstrated progress implementing TSCA by responding to
TSCAs statutory deadlines through the end of fiscal year 2018, including
promulgating rules, developing guidance, and releasing reports.
32
However, EPA faces key challenges to its ability to implement TSCA,
such as managing the risks posed by ongoing litigation, ensuring
appropriate resources, developing guidance to ensure consistency, and
ensuring that the new chemicals review process is efficient and
predictable.
EPA has responded to initial statutory deadlines under TSCA, as
amended by the Lautenberg Act, including requirements to promulgate
new rules, develop guidance, and release reports. For example, EPA
began 10 risk evaluations drawn from the 2014 update of the TSCA
Work Plan within 180 days of enactment of the Lautenberg Act
(§ 6(b)(2)(A));
submitted an initial report to Congress estimating capacity for and
resources needed to complete required risk evaluations within 6
months of enactment (§ 26(m)(1));
carried out and published in the Federal Register an inventory of
mercury supply, use, and trade in the United States by April 1, 2017.
33
(§ 8(b)(10)(B));
developed guidance to assist interested persons in developing and
submitting draft risk evaluations within 1 year of enactment
(§ 26(l)(5)); and
developed a plan for using alternative test methods to reduce use of
vertebrate animal testing within 2 years of enactment (§ 4(h)(2)(A)).
32
As we discuss below, several aspects of EPAs implementation of TSCA are in litigation.
GAO does not typically express an opinion in disputes pending before a court.
33
EPA must also do this every 3 years thereafter.
EPA Has
Demonstrated
Progress
Implementing TSCA
by Responding to
TSCA Statutory
Deadlines through the
End of Fiscal Year
2018, but Key
Challenges Remain
EPA Responded to TSCA
Statutory Deadlines
Page 29 GAO-19-270 Chemical Assessments
In addition, in four areas in which Congress required EPA to establish
processes and structures for TSCA, EPA finalized four rules detailing the
general processes for prioritizing and evaluating chemicals under TSCA,
known together as the Framework Rules. EPA responded to the 1-year
deadlines to establish three of the four Framework Rules.
34
These three
rules are
the risk prioritization rule, which explains EPAs process for
prioritizing existing chemicals for risk evaluation;
the risk evaluation process rule, which explains EPAs process for
conducting risk evaluations on existing chemicals; and
the inventory notification rule, which requires manufacturers and
processors of chemical substances to report which chemicals are
currently in commerce.
The fourth Framework Rule EPA issued, which had no issuance deadline,
implements a Lautenberg Act provision authorizing EPA to collect fees for
carrying out a number of different activities under TSCA, including
collecting fees from manufacturers and processors that submit new
chemicals or submit chemicals for significant new uses to EPA for review.
Though EPA responded to all of the statutory deadlines, some
environmental and industry stakeholder organizations we interviewed told
us that they do not believe this is a complete measure of how well EPA is
implementing TSCA. Representatives from one environmental
stakeholder organization told us in July 2018 that it is still too early to
assess how well EPA is implementing TSCA because none of the existing
chemical risk evaluations ongoing under the new process have been
released; the wording in the new rules and documentation is unclear; and
the risk prioritization rule, the risk evaluation rule, and the inventory reset
rule have been challenged in court. However, in January 2019 they told
us that they were too optimistic in their assessment of TSCA
implementation and believe EPA is falling behind in its progress. As of
December 2018, representatives from another environmental stakeholder
group told us that, while EPA has met a number of major statutory
deadlines, the agencys rules and other actions do not reflect the best
available science and are contrary to both the letter and intent of the new
34
The risk prioritization rule, risk evaluation rule, and inventory notification rule were
finalized June 22, 2017. The fees rule was finalized on September 27, 2018.
Page 30 GAO-19-270 Chemical Assessments
TSCA Act. However, in January 2019 an industry stakeholder
organization noted that the 2016 amendments to TSCA are generally
being implemented effectively and efficiently as Congress envisioned,
and the agency continues to meet important deadlines required by the
law. In addition, they also told us that EPA’s TSCA program is also
utilizing the best available science and a weight of the evidence approach
to make high quality chemical management decisions. Representatives
from industry stakeholder organizations we interviewed told us they
believe the rules are consistent with TSCA, but that EPA is not
consistently meeting the 90-day deadline to make determinations on new
chemicals or the 30-day deadline to make determinations on low-volume
exemptions.
35
EPA faces challenges with its ability to implement TSCA, such as
managing the risk posed by ongoing litigation, ensuring appropriate
resources, developing guidance documents to ensure consistency, and
ensuring that the new chemicals review process is efficient and
predictable.
Three of the four Framework Rules that EPA issued to implement TSCA
have been challenged in court: the risk prioritization rule, the risk
evaluation rule, and the inventory notification rule.
Procedures for Prioritization of Chemicals for Risk Evaluation
under the Toxic Substance Control Act (risk prioritization rule). In
Safer Chemicals, Healthy Families v. U.S. Environmental Protection
Agency, a collection of environmental and public health organizations
challenged several aspects of EPAs TSCA implementation, including
the risk prioritization rule.
36
Specifically, the environmental
organizations argue, among other things, that the plain language of
TSCA requires EPA to consider all conditions of use in prioritizing
chemicals for review under TSCA, rather than excluding, for example,
uses that EPA believes are legacy usesfor which a chemical is no
35
As we note below, the overall process can extend beyond the 90-day requirement.
36
Safer Chemicals, Healthy Families v. U.S. Environmental Protection Agency, Case No.
17-72260 (9th Cir.), filed August 10, 2017.
EPA Faces Challenges
Implementing TSCA
Three Rules Are Undergoing
Litigation
Page 31 GAO-19-270 Chemical Assessments
longer marketed.
37
EPA and chemical industry intervenors respond by
arguing that TSCA grants EPA discretion to determine what
conditions constitute a chemicals conditions of use and to generally
exclude legacy activitiesprimarily historical activities that do not
involve ongoing or prospective manufacturing, processing, or
distribution in commerce of a chemical substance as a product.
38
Procedures for Chemical Risk Evaluation under the Amended
Toxic Substances Control Act (risk evaluation rule). In Safer
Chemicals, Healthy Families v. U.S. Environmental Protection
Agency, the environmental organizations also contend that EPAs risk
evaluation rule is contrary to TSCA, in part because, as noted above,
the rule impermissiblyexcludes uses that the law requires EPA to
include in its risk evaluations. EPA and industry intervenors
responded by arguing that TSCA grants EPA discretion to determine
what conditions constitute a chemicals conditions of use. The
organizations also argued that the risk evaluation rule would deter
public participation in the risk evaluation process by imposing criminal
penalties on a member of the public who submits incomplete
information to EPA but does not impose similar penalties on
manufacturers.
39
In August 2018, the government moved to vacate
the penalty regulation, and the environmental organizations
consented to this motion.
37
Under TSCA, the process to designate the priority of chemical substances shall include
a consideration of the hazard and exposure potential of a chemical substance or a
category of chemical substances (including consideration of persistence and
bioaccumulation, potentially exposed or susceptible subpopulations and storage near
significant sources of drinking water), the conditions of use or significant changes in the
conditions of use of the chemical substance, and the volume or significant changes in the
volume of the chemical substance manufactured or processed.15 U.S.C. § 2605(b)(1)(A)
(emphasis added). TSCA defines conditions of useto mean the circumstances, as
determined by [the EPA] Administrator, under which a chemical substance is intended,
known, or reasonably foreseen to be manufactured, processed, distributed in commerce,
used, or disposed of. 15 U.S.C. § 2602(4).
38
An intervenor voluntarily enters a pending lawsuit because of a personal stake in it.
Black's Law Dictionary (10th ed. 2014).
39
Submission to EPA of inaccurate, incomplete, or misleading information pursuant to a
risk evaluation conducted pursuant to 15 U.S.C. 2605(b)(4)(B) is a prohibited act under 15
U.S.C. 2614, subject to penalties under 15 U.S.C. 2615 and Title 18 of the U.S. Code.40
C.F.R. § 702.31(d). The environmental organizations argued that because TSCA does not
require members of the public to submit information to EPA, this regulation would have
had the effect of penalizing voluntary information sharing, thus exceeding EPAs authority
under TSCA as well as being unconstitutionally vague.
Page 32 GAO-19-270 Chemical Assessments
Toxic Substances Control Act Inventory Notification (Active-
Inactive) Requirements (inventory notification rule). In
Environmental Defense Fund v. U.S. Environmental Protection
Agency,
40
an environmental organization challenged EPA’s inventory
notification rule, which EPA issued in response to a TSCA
requirement that EPA identify which chemicals in the TSCA inventory
are still in use and require substantiation of claims that chemical
identities constitute confidential business information that can be
withheld from public disclosure.
41
The environmental organization
argued, among other things, that the rule impermissibly allows any
persons to assert confidentiality claims for any chemical they
manufacture or process, rather than just the original claimant. EPA
and industry intervenors responded in part by arguing that TSCA
specifically allows any affected manufacturers to maintain an existing
confidentiality claim for a specific chemical identity, which the industry
intervenors assert constitutes critically important intellectual property.
OPPT officials told us they are trying to not anticipate the results of the
litigation and, instead, address the outcome of each case as it is decided.
They stated that they are staying aware of developments in ongoing
litigation and are constantly considering potential outcomes but believe it
would not be reasonable to prepare explicit resource plans for unknown
future scenarios. If EPA loses any of these lawsuits, it may need to
devote additional resources to implement the relevant provisions of
TSCA. For example, if the suit involving the risk evaluation rule is
successful, EPA may be forced to redo parts of its risk evaluations close
to the December 2019 deadline to finalize these evaluations. EPA is
required to complete its first 10 existing chemical evaluations not later
than 3 years after the date on which it initiated the risk evaluations, which
was December 2016. TSCA also allows for an extension of the risk
evaluation deadlines for up to 6 months if the agency deems it necessary.
The Lautenberg Act greatly increased OPPTs workload. Prior to the
enactment of the Lautenberg Act, EPA did not have deadlines for
completing existing chemical evaluations. Under the Lautenberg Act, EPA
must finalize 10 ongoing risk evaluations by December 2019, which
40
Environmental Defense Fund v. U.S. Environmental Protection Agency, No. 17-1201
(D.C. Cir), filed September 1, 2017.
41
15 U.S.C. § 2607(b)(4).
EPA Faces Challenges
Ensuring That
It Has
Appropriate Resources
Page 33 GAO-19-270 Chemical Assessments
represents a tight deadline, according to EPA officials.
42
Furthermore, the
law requires EPA to ensure that 20 risk evaluations are ongoing for high-
priority substances 3-1/2 years after enactment and that at least 20
chemical substances have been designated as low-priority substances.
43
In addition, under TSCA prior to the Lautenberg Act, a new chemical
could enter commerce after 90 days unless EPA took action to the
contrary. Under the Lautenberg Act, EPA is required to make a
determination on a new chemical before it can be manufacturedanother
source of increased workload.
44
Partially because of the increased workload, some OPPT officials told us
that they have concerns about staff capacity within OPPT. Officials in
both the Chemical Control Division (responsible for risk management)
and the Risk Assessment Division (responsible for risk assessment) said
that they do not have sufficient resources to do their work. This included
staff from all five technical teams we interviewed in the Risk Assessment
Division. Technical teams are working groups organized by discipline that
bring together experts from across OPPT branches. The Risk
Assessment Division is particularly affected by the heavy workload,
according to OPPT officials and representatives from an industry
42
See 15 U.S.C. § 2605(b)(2)(A), (b)(4)(C), (b)(4)(G)(i). EPA may extend the deadline for a
risk evaluation for not more than 6 months. 15 U.S.C. § 2605(b)(4)(G)(ii).
43
The Administrator shall designate as a high-priority substance a chemical substance
that the Administrator concludes, without consideration of costs or other nonrisk factors,
may present an unreasonable risk of injury to health or the environment because of a
potential hazard and a potential route of exposure under the conditions of use, including
an unreasonable risk to a potentially exposed or susceptible subpopulation identified as
relevant by the Administrator.15 U.S.C. § 2605(b)(1)(B)(i). The Administrator shall
designate a chemical substance as a low-priority substance if the Administrator
concludes, based on information sufficient to establish, without consideration of costs or
other nonrisk factors, that such substance does not meet the standard identified in clause
(i) for designating a chemical substance a high-priority substance.15 U.S.C. §
2605(b)(1)(B)(ii).
44
EPA must now make one of three determinations regarding a new chemical submission:
(1) that the chemical under the conditions of use presents an unreasonable risk; (2)(a) that
there is insufficient information available to make a judgment or that (b) in the absence of
such information, the chemical may present an unreasonable risk, or (c) the chemical is or
will be produced in substantial quantities that enter or may enter the environment or may
cause substantial human exposure; or (3) that the chemical or use is not likely to present
an unreasonable risk. 15 U.S.C. § 2604(a)(3). The law requires EPA to take further
actions with respect to chemicals in the first two categories. See 15 U.S.C. § 2604(e), (f).
EPA recently proposed to use significant new use rules under TSCA as an approach for
managing reasonably foreseeable uses of chemicals without making one of the
determinations listed above. 83 Fed. Reg. 52180 (Oct. 16, 2018).
Page 34 GAO-19-270 Chemical Assessments
stakeholder organization. The division must review all of the
premanufacture notices for new chemicals and contribute to the first 10
existing chemical evaluations.
45
Officials from the Chemical Control
Division told us that the Risk Assessment Division is struggling more
because its work requires more technical employees. The officials said
that EPA is hiring additional full-time equivalents (FTE), but it takes time
to train new people, and this will initially increase workload. Officials told
us that in July 2018, OPPT had about 300 FTEs and was authorized to
hire 40 additional FTEs. As of October 2018, OPPT officials told us that
they had hired or extended offers to 20 to 25 of that 40 and continued to
hire more employees. OPPT officials told us that reaching an appropriate
level of FTEsincluding recruiting and retaining staffis challenging.
OPPT officials said they expect that the recently announced initiative to
implement direct hiring authority for scientific and technical positions will
have a positive impact on these efforts.
To address the staffing challenge, staff have also been reassigned from
other parts of EPA to OPPT. For example, staff in the Safer Choice
Programan EPA program that helps consumers, businesses, and
purchasers find products that perform and are safer for human health and
the environmentwere redeployed to the Chemical Control and the Risk
Assessment Divisions. Representatives from both industry stakeholder
organizations we interviewed told us that it can be difficult to work with
recently reassigned staff who are not familiar with the chemicals they are
working on. Representatives from an industry stakeholder organization
told us that, in some cases, OPPT staff are ill-prepared to make decisions
about a premanufacture notice. OPPT senior officials said there is always
a learning curve for reassigned employees, but they do not put new
people in positions to make decisions on premanufacture notices. They
said that these decisions are never made by one person in a vacuum.
OPPT officials and staff told us that they are generally optimistic about an
upcoming reorganization of OPPT that will separate assessment and
management of new and existing chemicals programs and better align
the structure of OPPT with the focus of TSCAs provisions. For example,
the Chemical Control Division and the Risk Assessment Division currently
each handle both new and existing chemicals, and the planned
reorganization will divide the divisions into new and existing chemical
45
Anyone who plans to manufacture (including import) a new chemical substance for a
nonexempt commercial purpose is required by section 5 of TSCA to provide EPA with
notice before initiating the activity. This notice is called a premanufacture notice.
Page 35 GAO-19-270 Chemical Assessments
divisions. However, staff told us that they have concerns about whether
the new divisions will be adequately staffed, the timing of the
reorganization, and their future placements.
Staff from multiple technical teams we interviewed in the Risk
Assessment Division said that they are not sure if, after the
reorganization, the new divisions will be adequately staffed. Staff from
one technical team said there has been increased attrition in recent
years, partially because of concerns about the upcoming reorganization.
Staff from another technical team said that a large number of
management positions are unfilled. Staff from multiple technical teams
told us that it will take time after the reorganization to redistribute work
and train staff. Staff from one team said the reorganization is ill-timed
because there are currently too many other ongoing high-priority projects.
Staff from multiple technical teams also told us that they are experiencing
anxiety about their future placements and with whom they will work. In
commenting on a draft of this report, EPA stated that the concerns raised
by staff are likely common to any program undergoing change. OPPT
officials said they submitted the reorganization proposal to EPAs Office
of Mission Supportformerly the Office of Administration and Resources
Managementin October 2018 and that it could take several more
months as EPA management works out details with labor unions and
addresses other issues. Officials said that they anticipate implementing
the reorganization in early 2019.
OPPT senior officials said that now that OPPT has many new
responsibilities and a heavier workload, they are taking steps to improve
capacity by implementing the reorganization and hiring new staff. The
officials said that though there will inevitably be growing pains, the
changes are part of a larger plan specifically designed to better position
OPPT to implement TSCA. Senior officials also told us that they have
spent considerable time setting expectations for new and existing staff.
In tandem with the major changes that increased EPAs workload, the
2016 amendments to TSCA authorize EPA to establish fees to defray a
portion of the costs of administering TSCA sections 4, 5, and 6 and
collecting, processing, reviewing, providing access to, and protecting
information about chemical substances from disclosure, as appropriate,
under TSCA section 14.
46
Affected businesses began incurring fees
46
15 U.S.C. § 2625(b).
Page 36 GAO-19-270 Chemical Assessments
under the new rule as of October 1, 2018, but it is unclear whether the
fees collected will be sufficient to support relevant parts of the program.
OPPT officials told us that while they are uncertain how much the fees
rule will generate the first year, they believe that over the course of a few
years, the amount of money generated should stabilize. The first year is
where officials are not sure how much they may receive. Officials expect
to collect an average of $20 million per year over the next 3 fiscal years.
In fiscal year 2019, however, they expect to collect approximately $7
million to $8 million. According to EPA, the agency will be tracking its
costs and use that information to adjust future fees, if appropriate. As
required by law, EPA will evaluate and readjust, if necessary, the fees
every 3 years.
EPA estimates the average yearly cost of TSCA implementation for fiscal
years 2019 through 2021 to be $80,178,000. EPAs fiscal year 2019
budget justification shows $57,973,700 allocated to TSCA
implementation. However, EPA does not expect a budget shortfall in
fiscal year 2019 because, according to officials, they (1) have funds
available from 2018 to support fiscal year 2019 needs, (2) receive support
from other EPA offices like the Office of General Counsel and the Office
of Research and Development, (3) expect fiscal year 2019 costs to be
lower than the 3-year average described in the fees rule, and (4) expect
some indirect costs to be covered by non-TSCA budget categories.
47
EPA also faces challenges in developing guidance to ensure consistency
in implementing the law. OPPT officials said that, given the tight timelines
that TSCA requires, they have not yet created all the necessary guidance
for staff implementing the law. Officials likened it to building an airplane
as they fly it, as they must create guidance and processes, while
simultaneously applying them to chemical evaluations. Staff from four of
five technical teams we interviewed are either currently updating their
guidance, still developing their guidance, or have never developed
guidance before. Staff from two teams told us that they are developing
the guidance as they apply it to their work. OPPT officials told us that they
are using some guidance that was in place before the Lautenberg Act
was enacted, though they are working on updates.
47
In commenting on a draft of this report, EPA noted that the current budget situation is
helped by the fact that EPA will only be conducting 10 risk evaluations instead of the 20
required in later years.
EPA Faces Challenges
Developing Guidance t
o
Ensure Consistency
Page 37 GAO-19-270 Chemical Assessments
Representatives we interviewed from industry stakeholder organizations
said they want EPA to be clear about its standards for the new chemicals
program and how they are defining terms in TSCA. Representatives from
one industry stakeholder organization suggested that EPA should
establish some definitions and develop guidance on how to apply those
definitions, in order to help both chemical manufacturers and reviewers
within OPPT. In June 2018, EPA releasedPoints to Consider When
Preparing TSCA New Chemical Notifications,guidance that
representatives from industry stakeholder organizations said is helpful,
but they are still not sure how EPA is using information like the Points to
Consider guidance in its evaluations and against what standard EPA’s
reviewers are reviewing and assessing a chemical. Representatives we
interviewed from industry stakeholder organizations said that decisions on
new chemical reviews depend on individual reviewers because EPA has
not provided the reviewers with guidance that ensures consistency.
48
OPPT officials also said consistency is a challenge in conducting risk
assessments. Representatives we interviewed from environmental
stakeholder organizations did not mention consistency as an area of
challenge.
Representatives from both industry stakeholder organization we
interviewed also told us that the new chemicals program is too slow and
unpredictable, which can negatively affect innovation. For example,
representatives from one company told us in comments they provided
through an industry stakeholder organization we interviewed that it
submitted a premanufacture notice for a substance that would decrease
the potential for worker and environmental exposure while providing
improved product performance. The approval process extended to nearly
550 days compared to the 90 days it typically took to obtain approval prior
to TSCAs amendment. EPA can request extensions, and submitters can
voluntarily suspend the review process; therefore, the overall process can
extend beyond the 90-day requirement. For example, in the new chemical
review process, EPA first makes an initial determination. If a company
does not like this initial determination, it can request more time to provide
additional data or develop new data in an effort to get a positive final
determination. A company withdraws its submission prior to a final EPA
determination if it is clear the determination will not be favorable and the
48
In commenting on our draft report, EPA noted that OPPT officials add that the decision-
making process involves multiple layers of management officials and peer committees that
are designed to promote consistency across decisions.
EPA Faces Challenges
Ensuring That the New
Chemicals Review Process Is
Efficient and Predictable
Page 38 GAO-19-270 Chemical Assessments
chemical will be regulated.
49
EPA officials said the agency does not
violate the mandated timelines because submitters agree to voluntarily
suspend the review process. However, representatives from one industry
stakeholder organization told us that as of December 2018, with the
passage of time and greater familiarity with Lautenberg, OPPTs decision
making process has improved and is more predictable.
EPA officials said that historically, even among new chemicals for which
EPA completed review, 57 percent actually entered commerce. Officials
said that in the past companies submitted new chemicals just to see what
determinations EPA would make. Going forward, as of October 2018,
officials said they expect larger fees will result in some companies
choosing to be more selective in the chemicals they submit to the
program. In addition, EPA officials told us that after OPPTs
reorganization, a more devoted team will focus on pre-notice meetings
with companies. Officials said this should reduce some of the back and
forth with submitters, thereby improving timelines.
Representatives we interviewed from industry stakeholder organizations
also told us that delays motivate companies to introduce chemicals first in
foreign markets. For example, one company told us through comments it
provided through an industry stakeholder organization we interviewed that
it developed a new technology in the United States, but because of the
lengthy delays experienced with new chemicals reviewed under TSCA,
they will neither register nor commercialize the product in the United
States at this time. Rather, the company has decided to pursue
commercialization in Europe, which will enable the company to deliver the
benefits of this new technology to their customers in the European market
sooner than is possible in the United States.
50
We provided a draft of this report to EPA for its review and comment. We
received written comments from EPA that are reproduced in appendix I
and summarized below.
49
In commenting on our draft report, EPA noted that since 1979 to June 2016 about 3% of
submissions were withdrawn. From June 2016 to present about 9% of submissions were
withdrawn.
50
Foreign programs for assessing and managing chemicals operate within different
institutional structures.
Agency Comments
Page 39 GAO-19-270 Chemical Assessments
In its written comments, EPA stated that while the draft comprehensively
describes the challenges facing the TSCA and IRIS programs, it does not
appropriately address EPAs extensive progress in implementing TSCA,
and EPA recommended that our final report include information regarding
its accomplishments under the new law. Specifically, we report on the
steps EPA has taken to respond to the requirements of the law because
in many instances, whether EPAs response is legally sufficient is in
litigation, and GAO does not typically express a view on legal or factual
matters in dispute before a court. We have updated our report with
additional examples, which the agency provided in its comments, of steps
it has taken to implement TSCA.
In addition, EPA requested that we consider its progress made in
addressing and controlling toxic chemicals with respect to the five criteria
for removal from our high-risk list. The application of the high-risk criteria
was not within the scope of this report. Our forthcoming 2019 high-risk
update will address actions taken by agencies on the list, including EPA,
since the last update in 2017. EPA said that to monitor progress, it had
put into place a rigorous program; as a regular practice, EPA stated that
Deputy Assistant Administrators from the Office of Chemical Safety and
Pollution Prevention conduct monthly Business Review meetings with the
Office Directors, Deputy Office Directors, lead region representatives, and
other key staff. EPA stated that during these meetings they discuss their
organizationsoperations and performance, including TSCA
implementation status, using performance charts to track progress on
mission measures, identify and update countermeasures, and resolve
problems. However, over the year that we conducted our review, EPA
officials did not mention conducting such meetings and did not provide
documentation that such meetings took place.
Further, in its written comments, EPA provided technical comments on
the draft report, which we address as appropriate. In one comment, EPA
stated that instead of noting that the agency has successfully
implemented many statutory requirements, the draft report stated that
EPA responded to deadlines. We believe the report correctly
characterizes steps EPA has taken to implement TSCA, and, as noted
above, whether EPAs response is legally sufficient is in litigation, and
GAO does not typically express a view on legal or factual matters in
dispute before a court. In another case, the technical comments
contradicted facts that we gathered during our review. For instance, while
EPA stated that the draft report incorrectly noted that most of the IRIS
staff had been working on TSCA activities, we provide further information
to support our original statement; we replaced the term mostwith
Page 40 GAO-19-270 Chemical Assessments
specific data on the number of IRIS staff and the percentage of their time
that was devoted to TSCA activities.
Also in its technical comments, EPA stated that our analysis highlighted
uncertainty resulting from the agencys recent activities to ensure IRIS
Program efforts were aligned with the highest priorities of the agency.
EPA acknowledged that this action did result in a delay but that in the
long term, it would ensure that EPAs program and regional office
priorities are being addressed and that each office is fully engaged in the
development of IRIS assessments that will strengthen the agencys ability
to address its mission for protecting human health and the environment.
However, as we state in our report, prior to releasing results from the
initial program and regional office survey, EPA leadership in ORD made a
second request for a prioritized list of chemical assessments. According
to officials from the IRIS office, who were queried for advice, the second
request was made verbally at a meeting and did not provide the offices
with information on the basis for selecting priorities or the reason for
limiting the number of assessments to three or four chemicals. In addition,
the ultimate priority list EPA issued in December 2018 reflected the
priorities of two program offices and did not provide evidence that other
EPA program offices had no interest in IRIS assessments. Because EPA
did not identify the basis for program offices to select priorities or the
reason for limiting the number of chemicals to assess, the process was
not transparent, leaving room for uncertainty.
EPA also provided additional technical comments, which we have
incorporated as appropriate.
We are sending copies of this report to the appropriate congressional
committees, the Administrator of the Environmental Protection Agency,
and other interested parties. In addition, the report is available at no
charge on the GAO website at http://www.gao.gov.
Page 41 GAO-19-270 Chemical Assessments
If you or your staff members have any questions about this report, please
contact me at (202) 512-3841 or gomezj@gao.gov. Contact points for our
Offices of Congressional Relations and Public Affairs may be found on
the last page of this report. Key contributors to this report are listed in
appendix II.
Sincerely yours,
J. Alfredo Gómez
Director, Natural Resources and Environment
Appendix I: Comments from the Environmental
Protection Agency
Page 42 GAO-19-270 Chemical Assessments
Appendix I: Comments from the
Environmental Protection Agency
Appendix I: Comments from the Environmental
Protection Agency
Page 43 GAO-19-270 Chemical Assessments
Appendix I: Comments from the Environmental
Protection Agency
Page 44 GAO-19-270 Chemical Assessments
Appendix I: Comments from the Environmental
Protection Agency
Page 45 GAO-19-270 Chemical Assessments
Appendix I: Comments from the Environmental
Protection Agency
Page 46 GAO-19-270 Chemical Assessments
Appendix I: Comments from the Environmental
Protection Agency
Page 47 GAO-19-270 Chemical Assessments
Appendix II: GAO Contacts and Staff
Acknowledgments
Page 48 GAO-19-270 Chemical Assessments
J. Alfredo Gómez, (202) 512-3841 or gomezj@gao.gov
In addition to the contact named above, Diane Raynes (Assistant
Director), Summer Lingard-Smith (Analyst in Charge), Alisa Carrigan,
Tara Congdon, Richard P. Johnson, Amber Sinclair, and William Tedrick
made key contributions to this report. In addition Karen Howard, Dennis
Mayo, Dan Royer, and Sara Sullivan made important contributions.
Appendix II: GAO Contacts and Staff
Acknowledgments
GAO Contact
Staff
Acknowledgments
Related GAO Products
Page 49 GAO-19-270 Chemical Assessments
Chemical Innovation: Technologies to Make Processes and Products
More Sustainable. GAO-18-307. Washington, D.C.: February 8, 2018.
Chemicals Management: Observations on Human Health Risk
Assessment and Management by Selected Foreign Programs.
GAO-16-111R. Washington, D.C.: October 9, 2015.
Chemical Assessments: Agencies Coordinate Activities, but Additional
Action Could Enhance Efforts. GAO-14-763. Washington, D.C.:
September 29, 2014.
Chemical Regulation: Observations on the Toxic Substances Control Act
and EPA Implementation. GAO-13-696T. Washington, D.C.: June 13,
2013.
Chemical Assessments: An Agencywide Strategy May Help EPA Address
Unmet Needs for Integrated Risk Information System Assessments.
GAO-13-369. Washington, D.C.: May 10, 2013.
Toxic Substances: EPA Has Increased Efforts to Assess and Control
Chemicals but Could Strengthen Its Approach. GAO-13-249. Washington,
D.C.: March 22, 2013.
Chemical Assessments: Challenges Remain with EPA’s Integrated Risk
Information System Program. GAO-12-42. Washington, D.C.: December
9, 2011.
Chemical Assessments: Low Productivity and New Interagency Review
Process Limit the Usefulness and Credibility of EPA’s Integrated Risk
Information System. GAO-08-440. Washington D.C: March 7, 2008.
High-Risk Series: An Update. GAO-09-271. Washington D.C: January
2009.
High-Risk Series: Progress on Many High-Risk Areas, While Substantial
Efforts Needed on Others. GAO-17-317. Washington D.C: February 15,
2017.
Related GAO Products
(102673)
The Government Accountability Office, the audit, evaluation, and investigative
arm of Congress, exists to support Congress in meeting its constitutional
responsibilities and to help improve the performance and accountability of the
federal government for the American people. GAO examines the use of public
funds; evaluates federal programs and policies; and provides analyses,
recommendations, and other assistance to help Congress make informed
oversight, policy, and funding decisions. GAO’s commitment to good government
is reflected in its core values of accountability, integrity, and reliability.
The fastest and easiest way to obtain copies of GAO documents at no cost is
through GAO’s website (https://www.gao.gov). Each weekday afternoon, GAO
posts on its website newly released reports, testimony, and correspondence. To
have GAO e-mail you a list of newly posted products, go to https://www.gao.gov
and select “E-mail Updates.
The price of each GAO publication reflects GAO’s actual cost of production and
distribution and depends on the number of pages in the publication and whether
the publication is printed in color or black and white. Pricing and ordering
information is posted on GAO’s website, https://www.gao.gov/ordering.htm.
Place orders by calling (202) 512-6000, toll free (866) 801-7077, or
TDD (202) 512-2537.
Orders may be paid for using American Express, Discover Card, MasterCard,
Visa, check, or money order. Call for additional information.
Connect with GAO on Facebook, Flickr, Twitter, and YouTube.
Subscribe to our RSS Feeds or E-mail Updates. Listen to our Podcasts.
Visit GAO on the web at https://www.gao.gov.
Contact FraudNet:
Website: https://www.gao.gov/fraudnet/fraudnet.htm
Automated answering system: (800) 424-5454 or (202) 512-7700
Orice Williams Brown, Managing Director, WilliamsO@gao.gov, (202) 512-4400,
U.S. Government Accountability Office, 441 G Street NW, Room 7125,
Washington, DC 20548
Chuck Young, Managing Director, youngc[email protected]v, (202) 512-4800
U.S. Government Accountability Office, 441 G Street NW, Room 7149
Washington, DC 20548
James-Christian Blockwood, Managing Director, spel@gao.gov, (202) 512-4707
U.S. Government Accountability Office, 441 G Street NW, Room 7814,
Washington, DC 20548
GAO’s Mission
Obtaining Copies of
GAO Reports and
Testimony
Order by Phone
Connect with GAO
To Report Fraud,
Waste, and Abuse in
Federal Programs
Congressional
Relations
Public Affairs
Strategic Planning and
External Liaison
Please Print on Recycled Paper.